Cervical Intraepithelial Neoplasia clinical trials at University of California Health

• Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia

  Sorry, not yet accepting patients

  This phase II trial studies the effect of pembrolizumab on cervical intraepithelial neoplasia. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.

  at UCLA

Last updated: May 27, 2021